Biography:
Dr. Kim studied biochemistry at the Kyungpook National University in Korea and received her PhD degree at the same institution, majoring in biochemistry/neuroscience. She then joined several pharmaceutical companies from 1995 and founded Inventage Lab Inc with a novel microfluidics-based manufacturing platform in 2015. She is an active reviewer of The Korean Society of Toxicogeomics and Toxicoproteomics, and Molecular & Cellular Toxicology.
Development of a novel long-acting semaglutide, IVL3021, and its physicochemical and pharmacokinetic studies